Orgenesis Inc. (ORGS)
OTCMKTS · Delayed Price · Currency is USD
0.8500
-0.0500 (-5.56%)
Sep 17, 2025, 9:41 AM EDT
Orgenesis Market Cap
Orgenesis has a market cap or net worth of $5.91 million as of September 17, 2025. Its market cap has decreased by -84.54% in one year.
Market Cap
5.91M
Enterprise Value
22.97M
Revenue
899.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.85
Market Cap Chart
Since July 28, 2010, Orgenesis's market cap has increased from 252.93K to 5.91M, an increase of 2,237.13%. That is a compound annual growth rate of 23.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2025 | 5.91M | -39.85% |
| Dec 31, 2024 | 9.83M | -38.42% |
| Dec 29, 2023 | 15.96M | -67.96% |
| Dec 30, 2022 | 49.81M | -28.75% |
| Dec 31, 2021 | 69.91M | -35.68% |
| Dec 31, 2020 | 108.70M | 44.34% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 982.68M |
| Veradigm | 789.71M |
| Tian'an Technology Group | 782.91M |
| Elite Pharmaceuticals | 735.19M |
| Glass House Brands | 548.40M |
| Northwest Biotherapeutics | 379.14M |
| American Oncology Network | 353.52M |
| CytoDyn | 351.92M |